How to Use Amino Axiom's Compound Compare for Mechanism Research

What is Amino Axiom's Compound Compare?

Compound Compare is a free tool on Amino Axiom, a research information platform in the same network as Amino Foundry. It places two compounds in a side-by-side layout that pairs structural attributes with a summary of the research literature for each. It lives at Amino Axiom Compound Compare, and it is meant for orientation: confirming what two compounds are and where they differ before bench work or deeper reading begins.

For mechanism research, the useful feature is the forced alignment. Two compounds are described in the same fields, so differences stand out instead of hiding in differently written sources.

Why compare compounds side by side for mechanism work?

Mechanism questions are almost always comparative. A researcher rarely asks what one compound does in isolation; the question is usually how one compound's reported pathway engagement differs from a related or competing candidate. A single-compound page answers the first question. A paired view answers the second, because shared fields let the reader check class, size and target in one pass.

Side-by-side reading also exposes naming and scope problems. Two compounds that circulate under similar labels can turn out to differ in class, and the structural rows show that immediately.

What does the comparison show for each compound?

The view is organized around a few repeating groups. Identity covers the name and class. Structure covers formula and molecular weight, which indicate size and composition. The literature group summarizes what published work associates with the compound, including the receptor or pathway named in that work. The tool states what each row displays and nothing more, so a reader should treat every row as a pointer back to primary sources.

A workable reading order is identity, then structure, then literature. Structure comes before literature because molecular size and class constrain which mechanisms are plausible, and that filter makes the literature easier to weigh.

How do you read the structural rows?

Start with the molecular weight and formula. They are the quickest check on whether two compounds belong in the same framework. A comparison that pairs a roughly 640 g/mol tetrapeptide with a 2,000-plus g/mol peptide is comparing different classes of molecule, and any mechanism claim should be read with that gap in mind.

Next, note what the formula implies: the presence of sulfur, for example, indicates cysteine or methionine residues, which matters for any discussion of oxidation chemistry. These are observations from the formula itself, and they are cheap to make before reading a single paper.

What does a worked comparison look like with catalog compounds?

Three Amino Foundry catalog entries make a good trio because they are often discussed together in cellular-energetics and receptor literature while differing in structure. ARA-290 is listed with formula C51H84N16O21, molecular weight 1257.3 g/mol and CAS 1208243-50-8. SS-31 is listed with formula C32H49N9O5, molecular weight 639.80 g/mol and CAS 736992-21-5. MOTS-c is listed with formula C100H152N28O22S2, molecular weight 2174.59 g/mol and CAS 1627580-64-6.

Placed in a comparison, the structural rows already tell a story. SS-31 is the smallest at about 640 g/mol. ARA-290 sits near 1,257 g/mol. MOTS-c is the largest at about 2,175 g/mol and is the only one of the three whose formula contains sulfur. Those differences set expectations before any mechanism text is read: three different sizes, three different chemistries, and three different literatures.

How should the literature rows be interpreted?

The literature rows summarize what published studies report, which is not the same as what has been demonstrated. A careful reader separates three kinds of statement: direct interaction measured in a defined system, pathway activity reported in cell or animal models, and hypotheses. A comparison view can place two summaries next to each other, but it cannot make them equal in evidentiary weight.

Applied to the trio above, a researcher would note for each compound which receptor or pathway the literature names, in what model system, and whether the work is a direct measurement or an inference. ARA-290 is described in the catalog as a peptide associated with the innate repair receptor, a heteromeric receptor assembly. MOTS-c is described as a mitochondrial-derived peptide. SS-31 is a small peptide discussed in the mitochondrial literature. Those are starting labels, and each one needs its primary sources behind it.

How do you build a comparison table of your own?

A short note-taking routine keeps comparison work honest. Follow these steps for any pair:

1. Record each compound's name, class and catalog identifiers (formula, molecular weight, CAS).
2. Note the structural difference that is most likely to matter, usually size or composition.
3. For each literature claim, write the model system next to it.
4. Mark each claim as a direct measurement, a pathway readout or a hypothesis.
5. List the primary sources to read first, ordered by how much of the claim they carry.

The result is a small table that outlasts the comparison view itself and makes disagreements between sources visible.

What mistakes are common when reading a comparison?

The most frequent error is treating parallel layout as parallel evidence. Two columns of equal length imply two literatures of equal depth, and that is often untrue. One compound may have a large body of published work and the other only a handful of studies, and a side-by-side view will not flag the imbalance unless the reader counts sources deliberately.

A second error is comparing across classes without adjusting the framework. A peptide acting at a cell-surface receptor and a molecule discussed in mitochondrial biology answer different kinds of questions, and mixing their vocabularies produces vague conclusions. A third is skipping the structural rows because they look like boilerplate. In practice the formula and weight are the fastest sanity check available, and they catch mislabeled or conflated entries early.

How does Compound Compare fit with the rest of a literature review?

Compound Compare is best placed at the start of a review, after a candidate list exists and before full-text reading begins. It narrows a list of several compounds to the pairs worth reading about in depth, and it supplies a consistent vocabulary for notes. Later stages, such as reading primary papers and checking analytical documentation for a specific lot, sit outside the tool.

Keeping those stages separate is a matter of discipline. A comparison summarizes; a paper reports; a Certificate of Analysis verifies. Each answers a different question, and none substitutes for another.

What are the limits of a comparison view?

A comparison tool inherits the limits of summaries. It compresses nuance about concentrations in vitro, model choice and conflicting results, and it describes compounds in general rather than any specific lot. Identity for a specific lot is a separate question answered by analytical documentation, which is covered in the Amino Foundry guide to reading a Certificate of Analysis. Purity and its measurement are covered in the article on peptide purity.

Used this way, Compound Compare is an orientation layer: it shortens the path to the right primary papers and makes structural mismatches obvious early. Researchers who want to see the wider platform can start from the Amino Axiom homepage, and those who want Amino Foundry's own listings can browse all compounds.

---

This article is for informational and laboratory research purposes only. The compounds discussed are research chemicals, not drugs, supplements, or food, and are not intended for human consumption. Amino Foundry does not sell products intended for human use. Researchers are responsible for compliance with all applicable local, state, and federal regulations.